288 related articles for article (PubMed ID: 12808455)
21. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
Rätsch A; Joos S; Kioschis P; Lichter P
Exp Cell Res; 2002 Feb; 273(1):12-20. PubMed ID: 11795942
[TBL] [Abstract][Full Text] [Related]
22. Splenic small B-cell lymphoma with IGH/BCL3 translocation.
Soma LA; Gollin SM; Remstein ED; Ketterling RP; Flynn HC; Rajasenan KK; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):218-30. PubMed ID: 16426923
[TBL] [Abstract][Full Text] [Related]
23. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.
Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G
Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087
[TBL] [Abstract][Full Text] [Related]
25. BCL-6: rearrangement and mutation in lymphoma.
Wagner SD; Kaeda JS
Methods Mol Med; 2005; 115():251-70. PubMed ID: 15998973
[TBL] [Abstract][Full Text] [Related]
26. Re: Akasaka, H., et al., Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res., 60: 2335-2341, 2000.
Lossos IS; Jacobs Y; Cleary ML; Levy R
Cancer Res; 2001 Oct; 61(19):7363-4. PubMed ID: 11585778
[No Abstract] [Full Text] [Related]
27. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
28. [Clinical integration and grouping of malignant lymphoma].
Fukuhara S
Rinsho Ketsueki; 2002 Mar; 43(3):146-50. PubMed ID: 11979743
[No Abstract] [Full Text] [Related]
29. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
[TBL] [Abstract][Full Text] [Related]
30. Oncogene probes in the detection of human cancer.
Showe LC; Croce CM
Clin Physiol Biochem; 1987; 5(3-4):227-37. PubMed ID: 3621798
[TBL] [Abstract][Full Text] [Related]
31. [Large-cell diffuse B-cell lymphoma: heterogenous origin and prognosis from the aspect of modern diagnosis].
Soukup J; Krsková L; Mrhalová M; Kodet R; Campr V; Kubácková K; Trnĕný M
Cas Lek Cesk; 2003; 142(7):417-22. PubMed ID: 14515445
[TBL] [Abstract][Full Text] [Related]
32. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
33. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
34. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
[TBL] [Abstract][Full Text] [Related]
35. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex.
Raghavan SC; Swanson PC; Wu X; Hsieh CL; Lieber MR
Nature; 2004 Mar; 428(6978):88-93. PubMed ID: 14999286
[TBL] [Abstract][Full Text] [Related]
36. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
Boström H; Leuchowius KJ; Hallböök H; Nordgren A; Thörn I; Thorselius M; Rosenquist R; Söderberg O; Sundström C
Eur J Haematol; 2008 Sep; 81(3):218-25. PubMed ID: 18510704
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Herry A; Morel F; De Braekeleer M
Cytogenet Genome Res; 2007; 118(2-4):345-52. PubMed ID: 18000389
[TBL] [Abstract][Full Text] [Related]
38. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
39. The expression pattern of the AML1 gene in non-Hodgkin's B-cell lymphomas and normal B lymphocytes.
Chimienti G; Alaibac M; Marzullo F; Carbone A; Pepe G
Blood Cells Mol Dis; 2000 Jun; 26(3):186-92. PubMed ID: 10950938
[TBL] [Abstract][Full Text] [Related]
40. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS
Br J Haematol; 2005 Jul; 130(1):36-42. PubMed ID: 15982342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
